Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
addiction, alcoholism and weight loss
Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.
Weight loss drugs like Ozempic may help reduce overdose risks: Study
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Ozempic Microdosing Is Gaining Popularity. Does It Work for Weight Loss?
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can still help people lose weight with fewer side effects at a lower cost.
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
The future of the weight loss market might not revolve around GLP-1 drugs.
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
Weight-Loss Drugs Cut Drug and Alcohol Abuse, According to New Study
Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence that the drugs yield health benefits beyond diabetes and weight loss.
Can Weight Loss Drugs Also Treat Addiction?
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs like Ozempic and Mounjaro, which also treat diabetes, may help users battling drug and alcohol abuse as well. A study published in the Addiction medical journal Wednesday showed roughy 1.
5d
on MSN
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...
News Medical on MSN
2d
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
11d
on MSN
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Judge unseals new evidence
2024 induction ceremony
Philip Zimbardo dies at 91
Netanyahu's home targeted
G7 ministers back Ukraine
OK classroom Bible suit
Probes near miss in Austin
Nationwide blackout in Cuba
PG&E shuts off power
NC breaks turnout record
NK sending troops to RU?
School shooting report
Fire prompts evacuations
Three Americans detained
La Nina could arrive soon
Republicans appeal ruling
Frozen waffles recalled
Ex-MN congressman dies
Bladder cancer drug pulled
Emergency abortion ruling
At decade-high level
To furlough 700 workers
Challenges military listing
$4M LAPD fentanyl seizure
Calif. oil refinery closure
Antitrust ruling delayed
Opioid suits settlement deal
Feedback